Sponsored Breakfast Symposia

Friday 15th June 2018

Presentation Title: How does new data inform our approach to acute and chronic management of Acute Coronary Syndrome?
Time: 0725 - 0740 Breakfast Served
          0740 - 0840 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Brevet Lounge              
Chair & Speaker: Associate Professor Gerry Devlin, Waikato Hospital
Speakers: Professor Stephen Nicholls, South Australian Health & Medical Research Institute, 
 Associate Professor John Elliott, Christchurch Hospital

Synopsis:
An overview of some recent data presented in the Acute Coronary Syndrome patient population, practical application for both acute and chronic management strategies, with patient case studies

 

Presentation Title: CHALLENGING THE PARADIGM: Entresto® (sacubitril/valsartan) in systolic heart failure
Time: 0725 - 0740 Breakfast Served
           0740 - 0840 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Morrison Room 
Speakers: Professor Richard Troughton, Christchurch Heart Institute & Professor Peter Macdonald, St Vincents Hospital, NSW

Topic 1: HFrEF and Neurohormonal Systems 
Topic 2: Key Results from PARADIGM-HF 
Topic 3: Sacubitril/valsartan clinical experience & case studies 

 

Saturday 16th June 2018

Philips

Presentation Title: SYNTAX II: A State-of-the-Art Approach to Managing PCI
Time: 0730 - 0745 Breakfast Served
           0745 - 0845 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Morrison Room                
Moderator and Speaker:  Dr David Smyth, Christchurch Hospital
Speakers: Dr Aniket Puri, Christchurch Hospital & Dr Rajesh Nair, Waikato Hospital

Topic 1: SYNTAX II: A State-of-the-Art Approach to Managing PCI 
Topic 2: The Critical Role of Physiology in State-of-the-Art PCI 
Topic 3: The Critical Role of IVUS in State-of-the-Art PCI 

Synopsis:
This session will address
  • The key outcomes of the Syntax II Trial and understand the clinical implications of this data
  • Incorporating State-of-the-art technologies and procedural techniques to improve clinical outcomes in complex
   revascularisation
  • Recognising the critical role of iFR and IVUS in simplifying decision making and providing confidence in treatment
  • Expected benefits on health economics and patient outcomes derived from contemporary PCI practice       

 

Presentation Title: Critical appraisal of PCSK9 antibody trials: the ODYSSEY journey and implications for clinical practice
Time: 0730 - 0745 Breakfast Served
           0745 - 0845 Symposium
NB: Transportation to the venue will be provided from the accommodation venues, exact schedule to be advised closer to the Meeting
Room: Brevet Lounge              
Speaker:  Professor Harvey White, Auckland City Hospital

Synopsis:
What do you know about PCSk9 inhibitors?  Are they effective? Are they safe?  Do they reduce the risk of stroke?  Do they reduce total mortality?  How much do they cost?  Should they be available and funded for patients with ACS  or just for familial dyslipidaemia? 

The latest results will be presented from the 3 PCSK9 trials and the implications for clinical practice



© 2018 CSANZ | Conference is managed by The Conference Company

Designed & Developed by 72DPI